Inventor
Mark E. Scott
Inventor
Edmonton, CA
Overview
Patents· 19 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
A61KPreparations for medical, dental or toiletry purposes16%
C07BGeneral methods of organic chemistry7%
C07CAcyclic or carbocyclic compounds5%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture5%
C12YEnzymes5%
C12NMicroorganisms or enzymes3%
B65DContainers for storage or transport of articles or materials, e.g. bags, barrels, bottles, boxes, cans, cartons, crates, drums, jars, tanks, hoppers, forwarding containers2%
G01FMeasuring volume, volume flow, mass flow or liquid level2%
PatentTitleYear
11,017,346Methods, apparatus, and systems for generating a content-related notification using a container interface display apparatus202110,815,214Regioselective N-2 arylation of indazoles202010,745,412Processes for preparing ACC inhibitors and solid forms thereof202010,689,369Substituted indazole compounds as RORgammaT inhibitors and uses thereof202010,519,165Processes for preparing ACC inhibitors and solid forms thereof201910,487,090Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof201910,435,386Regioselective N-2 arylation of indazoles201910,344,000Substituted bicyclic pyrazole compounds as RORgammaT inhibitors and uses thereof201910,287,272Substituted indazole compounds as RORgammaT inhibitors and uses thereof201910,072,025Ethyl N-boc piperidinyl pyrazolo pyridones as Janus kinase inhibitors201810,059,705Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors20189,957,265N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors20189,957,264Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors20189,725,445'Cycloalkyl nitrile pyrazolo pyridones as Janus kinase inhibitors'20179,580,407'Regioselective N-2 arylation of indazoles'20179,486,448'Pyrrolidine derived beta 3 adrenergic receptor agonists'20168,993,756'Pyrrolopyrimidines as janus kinase inhibitors'20158,937,077'Bicyclic diamines as janus kinase inhibitors'20158,604,038'Pyrrolidine derived beta 3 adrenergic receptor agonists'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2020Patents assigned to MERCK SHARP & DOHME (15)· patent assignee history
2013–2016Patents assigned to SCOTT MARK E (3)· patent assignee history
2013–2015Patents assigned to ANTHONY NEVILLE J (2)· patent assignee history
2013–2018Based in Andover, MA, US· patent location history
2015–2016Patents assigned to CAMMARANO CAROLYN MICHELE (2)· patent assignee history
2016–2020Based in Edmonton, CA· patent location history
2019–2020Patents assigned to GILEAD SCIENCES INC (2)· patent assignee history
2019Based in Foster City, CA, US· patent location history
2019Based in Alberta, CA· patent location history
2021Based in Germantown, TN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| MERCK SHARP & DOHME | 15 | 2013–2020 |
| SCOTT MARK Eself | 3 | 2013–2016 |
| ANTHONY NEVILLE J | 2 | 2013–2015 |
| CAMMARANO CAROLYN MICHELE | 2 | 2015–2016 |
| GILEAD SCIENCES INC | 2 | 2019–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| Edmonton, CA | 8 | 2016–2020 |
| Andover, Massachusetts, US | 8 | 2013–2018 |
| Germantown, TN, US | 1 | 2021 |
| Foster City, California, US | 1 | 2019 |
| Alberta, CA | 1 | 2019 |